Ayurvedic management of Diabetic Macular Edema: A case report
DOI:
https://doi.org/10.70066/jahm.v13i7.1947Keywords:
Case report, Diabetic Macular Edema (DME), Vascular Endothelial Growth Factor (VEGF), Kriyakalpa, Koshtashodhana, Basti, Optical coherence Tomography (OCT)Abstract
Background: Macular oedema (ME), characterised by exudative fluid accumulation in the macula, is the most common form of sight-threatening retinopathy in people with diabetes (DME) and non-diabetic population contributes 5th major cause in preventable blindness. 1/3rd of diabetic population develops signs & among those 1/3rd develops vision threatening situation. The patho-physiological processes begin with chronic hyperglycaemia, and interplay between vascular endothelial growth factor (VEGF) and inflammatory mediators. Clinical findings: A 76-year-old-male patient presented with complaints of diminished vision in left eye since 5 months. After a fundoscopic examination, he was diagnosed with left eye diabetic macular oedema, confirmed with Optical coherence Tomography (OCT). As a standard protocol, intra-vitreal injections were advised but patient was willing for Ayurveda treatment. The patient was assessed through Ayurveda protocol and specific treatment planned starting from Deepana, Paachana, Koshtashodhana, Basti with specific topical eye treatments (Kriyakalpa). Outcome: Encouraging results obtained which might have reduced fluid accumulation in the macular region and there was significant improvement seen in Retinal Pigment Epithelial (RPE) thickness. Conclusion: Significant improvement in reducing the macular oedema with ayurvedic management can be seen. As patient had cataract visual improvement cannot be stated as a significant factor in this case.
References
Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S, Taylor HR; Vision Loss Expert Group. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health. 2013 Dec;1(6): e339-49.Available from: https://www.sciencedirect.com/science/article/pii/S2214109X1370113X
https://doi.org/10.1016/s2214-109x(13)70113-x
Sorour OA, Levine ES, Baumal CR, Elnahry AG, Braun P, Girgis J, Waheed NK. Persistent diabetic macular edema: definition, incidence, biomarkers, and treatment methods. Surv Ophthalmol. 2023;68(2):147–74.
https://doi.org/10.1016/j.survophthal.2022.11.008
Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A, Lopez-Galvez M, Navarro-Gil R, Verges R. Diabetic macular edema pathophysiology: vasogenic versus inflammatory. J Diabetes Res [Internet]. 2016 [cited 2020 May 11];2016. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059543/ https://doi.org/10.1155/2016/2156273
Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556– 64.https://doi.org/10.2337/dc11-1909
Gemmy M, Yoon YH, Chen LJ, Chen S, George TM, et al. Diabetic macular edema: evidence-based treatment recommendations for Asian countries. Clin Exp Ophthalmol. 2018 Jan;46(1):75– 86.https://doi.org/10.1111/ceo.12999
Acharya Sushruta, Shastri A. Sushruta Samhita. Vol. II, Uttartantra, Chapter 7, Shloka 25–26. Varanasi: Chaukhamba Sanskrit Sansthana; 2017
Makodiya A, Sharma A, Shukla R, Ramani H. Effect of Dashamooladi Basti in the short-term management of Amavata w.s.r. to rheumatoid arthritis. Int Res J Ayurveda Yoga. 2022; 5:60–9. http://dx.doi.org/10.47223/IRJAY.2022.5109
Lodha S, Karade R. Clinical evaluation of Vaitarana Basti along with Dhanwantara Taila Matra Basti in Amavata: a case series. Int J Res Ayurveda Pharm. 2020; 11:12–5.
http://dx.doi.org/10.7897/2277-4343.1106177
Chakraborty S, Das A. A classical Ayurveda review on Haridra. Ayushdhara [Internet]. 2020 Nov 30 [cited 2025 May 24];7(Supply 1):47–55. Available from: https://ayushdhara.in/index.php/ayushdhara/article/view/579 http://dx.doi.org/10.47070/ayushdhara.v7iSupply1.579
Manwar RC, Bhat PM. Indigenous drugs in ophthalmology: a review. Int J Res Ayurveda Pharm. 2020;11(3):108– 10.http://dx.doi.org/10.7897/2277-4343.110371
Gavadiya SK, Sharma T, Bapna VM. External applications of Shigru (Moringa oleifera Lam): a comprehensive review. J Indian Syst Med. 2022;10(4):241– 50.http://dx.doi.org/10.4103/jism.jism_48_22
Choudhury C. Standardization of Bidalaka Kriyakalpa with specific reference to Saindhavadi Yoga - a pilot study. J Ayurveda Holist Med. 2021;7(3).https://doi.org/10.70066/jahm.v7i3.411 13. Dr Arun kumar V. ROLE OF AYURVEDA IN MANAGEMENT OF LIFESTYLE DISORDERS OF NETRA. JAHM *Internet+. 2021Jul.13 [cited 2025Jul.22];9(3). Available from: https://jahm.co.in/index.php/jahm/article/view/435 https://doi.org/10.70066/jahm.v9i3.435
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr Anjali Avinash Khose, Dr Arunkumar Bapurao Biradar; Dr. Vishwanath Wasedar, Dr Sangeetha M Kanna
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.
